Owens & Minor Inc. (OMI, Financials) shares plummeted 35.2% on Monday, closing at $9.23, after the company said it is moving forward with its planned acquisition of Rotech Healthcare Holdings, announcing that it has begun raising funds to support the deal. The company expects to finalize the purchase in the first half of 2025.
Owens & Minor projects a net loss between $288 million and $311 million but sales for the fourth quarter between $2.67 billion and $2.70 billion. A major component of the loss is a $310 million goodwill impairment charge linked to its Apria subsidiary, which the firm ascribed to market conditionsincluding a declining stock price and increasing interest rates.
With a net loss ranging from $355 million to $378 million, full-year income for 2024 is anticipated to be between $10.67 billion and $10.70 billion. Notwithstanding the losses, the business highlighted strong success in its Patient Direct division, which witnessed consistent mid-single-digit growth. Over the previous year, Owens & Minor also lowered overall debt by more than $240 million.
Pesicka said he still sees great demand for the company's goods and services and is hopeful about its long-term plan.
On Feb. 28, Owens & Minor will provide its complete fourth-quarter and yearly financial figures.
This article first appeared on GuruFocus.免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。